MENINGITIS B STUDY
Meningitis B is an uncommon but very serious disease caused by a bacterial infection of the lining of the brain and spinal cord. Meningitis B bacteria lives within the nose and throat and is spread through close contact such as coughing, sneezing, kissing and sharing drinks/food.
Meningitis is potentially fatal as 1 in 10 people infected may die, sometimes within 24 hours. Good news! There are vaccines available to prevent Meningitis B. Although Tennessee does not list Meningitis B vaccine in required immunizations, one dose is required for admission to most colleges and universities. If you have not had meningitis shot you may consider participating in a research study. The purpose of this study is to evaluate the effectiveness of 2 or 3 doses of Bexsero (a FDA approved Group B vaccine) and Menvo (FDA approved for A,C,W,Y) compared to an investigator vaccine of the combination of both to cover all five meningitis groups (A,B,C,W,Y).
Who is eligible to participate?
In order to qualify you must be:
What does the study involve?
Participants must be willing to receive four injections and blood draws. You will receive compensation of $50 per visit and $10 per phone call.